Editas Medicine is a clinical-stage biotechnology company pioneering CRISPR-based gene editing therapies for rare and serious diseases. The company leverages CRISPR/Cas9 and CRISPR/Cas12a genome editing systems to develop in vivo and ex vivo gene editing medicines. Currently focused on hemoglobinopathies (sickle cell disease, beta thalassemia), cardiovascular diseases, and oncology through cellular therapy partnerships with Bristol-Myers-Squibb and Immatics N.V. Signal Plug searches live against editasmedicine.com's mail server to find and verify email addresses for any Editas Medicine, Inc. employee.
Signal Plug searches live against editasmedicine.com's mail server — not a static database. Get a verified email for any Editas Medicine, Inc. employee with confidence score in under 2 seconds.
94% accuracy · No credit card required · 10 free searches/month
Editas Medicine is a clinical-stage biotechnology company pioneering CRISPR-based gene editing therapies for rare and serious diseases. The company leverages CRISPR/Cas9 and CRISPR/Cas12a genome editing systems to develop in vivo and ex vivo gene editing medicines. Currently focused on hemoglobinopathies (sickle cell disease, beta thalassemia), cardiovascular diseases, and oncology through cellular therapy partnerships with Bristol-Myers-Squibb and Immatics N.V.
Competitive Advantage
Editas formerly operated under the name Gengine, Inc. before rebranding; The company specifically develops in vivo gene editing medicines that edit genes directly inside the body rather than only ex vivo approaches; Editas has dual CRISPR platform technology using both Cas9 and Cas12a systems for broader therapeutic applications; The company maintains strategic partnerships with major pharma (Bristol-Myers-Squibb) and specialized biotech (Immatics) for cellular therapy development; Leadership includes Linda C. Burkly as Chief Scientific Officer and Gregory Whitehead as Chief Technical and Quality Officer, suggesting strong technical depth.
The most commonly verified format at Editas Medicine, Inc.:
Medium ConfidenceSignal Plug tests all common patterns against Editas Medicine, Inc.'s live mail server and returns whichever passes the SMTP check.
Run a live search for Editas Medicine, Inc. →Data-driven signals to help you prospect Editas Medicine, Inc. effectively.
Editas recruits from top-tier research institutions and biotech firms seeking experienced gene editing scientists and clinical development professionals. The company attracts venture capital, institutional investors, and strategic partners in large pharma seeking novel CRISPR-based therapeutic platforms.
Primary Contact
Chief Scientific Officer
Tuesday–Thursday, 9am–11am
Signal Plug performs live SMTP verification against editasmedicine.com's mail server — not a static scraped database — which means results reflect the real, current state of Editas Medicine, Inc.'s email infrastructure. Here's how to run a lookup:
Create a free account
Sign up at Signal Plug in under 30 seconds. No credit card required. The Free plan includes 10 searches per month so you can test the tool with real Editas Medicine, Inc. contacts before upgrading.
Enter the contact's name
Type the first and last name of the Editas Medicine, Inc. employee you want to reach. Signal Plug handles all seniority levels, from C-suite to individual contributors.
Enter the domain
Use editasmedicine.com. Signal Plug tests all common naming patterns automatically and returns only the format that passes the SMTP check.
Get a verified result
Signal Plug returns an email address with a confidence score (0–100) and deliverability status (Valid, Risky, or Catch-all) within 2 seconds. The confidence score tells you how reliable the result is before you use it.
Export and use
One-click CSV export lets you bring Editas Medicine, Inc. contacts into Salesforce, HubSpot, Outreach, Lemlist, or any other tool in your stack. Growth and Scale plan users can run bulk lookups across an entire list of Editas Medicine, Inc. names in a single batch.
Editas Medicine, Inc. competes directly with CRISPR Therapeutics, Sangamo Therapeutics, Intellia Therapeutics and others in the Biotechnology space.
| Company | Size | Tier | Focus | Email Format |
|---|---|---|---|---|
| Editas Medicine, Inc. | Gene Editing, Clinical-Stage Drug Development | firstname.lastname | ||
| CRISPR Therapeutics | — | — | — | firstname.lastname |
| Sangamo Therapeutics | — | — | — | firstname.lastname |
| Intellia Therapeutics | — | — | — | firstname.lastname |
| Beam Therapeutics | — | — | — | firstname.lastname |
Whether you're running outbound sales, recruiting, or building a partnership list, these are the roles most frequently contacted at Biotechnology like Editas Medicine, Inc..
Based on Editas Medicine, Inc.'s profile, the highest-value contacts for outbound are:
Signal Plug works for any role at any seniority level at editasmedicine.com. If you have a name and the domain, you can find a verified email.
How well Editas Medicine, Inc. fits a typical B2B outbound pipeline, based on available signals.
Good Fit
Funnel Fit Score
Most email finder tools pull from static databases of scraped email addresses. These databases go stale as people change jobs and companies update their email infrastructure. Signal Plug takes a different approach: every search performs a live check against editasmedicine.com's mail server using SMTP verification. This means results reflect the current state of Editas Medicine, Inc.'s email system — not a cached result from months or years ago.
Signal Plug enriches every result with supporting data: a confidence score (0–100), deliverability status (Valid, Risky, or Catch-all), job title where available, and LinkedIn profile URL. This context helps you prioritize which Editas Medicine, Inc. contacts to email first and personalize your outreach before you hit send. Plans start at $29/month for 500 searches — no annual contracts or seat fees.
Signal Plug performs a live SMTP check against editasmedicine.com's mail server for every query — not a static database lookup. Our platform-wide accuracy rate is 94%. Each result comes with a confidence score (0–100) so you can gauge reliability before using the address.
Free plan: 10 searches. Starter ($29/mo): 500. Growth ($149/mo): 2,000. Scale ($299/mo): 5,000. No company-specific caps.
No. Signal Plug generates and verifies emails in real time via SMTP checks — no static database of Editas Medicine, Inc. employee emails is maintained.
Yes. Growth and Scale plan users can upload a CSV of names and run bulk lookups against editasmedicine.com in a single batch.
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and is a gene editing technology that can revise, remove, and replace DNA in targeted ways; Editas uses CRISPR/Cas9 and CRISPR/Cas12a systems to develop transformative medicines.
Editas is concentrating on hemoglobinopathies (sickle cell disease, beta thalassemia), cardiovascular diseases (hyperlipidemia, atherosclerotic cardiovascular disease), and oncology through cellular therapy partnerships.
Editas Medicine is headquartered in Cambridge, Massachusetts, with an additional facility in Boulder, Colorado.
Editas develops both in vivo gene editing medicines (which edit genes inside the body) and ex vivo approaches including hematopoietic stem cell therapies.
Signal Plug searches in real time against editasmedicine.com's mail server to find and verify email addresses for Editas Medicine, Inc. employees. Enter a name, enter the domain, get a verified result with a confidence score in under 2 seconds.
Start finding emails free →10 free searches · No credit card required · Upgrade from $29/month